For the readers interested in the stock health of Genesis Healthcare Inc. (GEN). It is currently valued at $0.59. When the transactions were called off in the previous session, Stock hit the highs of $0.6899, after setting-off with the price of $0.5602. Company’s stock value dipped to $0.5352 during the trading on the day. When the trading was stopped its value was $0.54.
Recently in News on December 23, 2020, Franklin Woods Center Among the First Long-Term Care Facilities in Maryland to Vaccinate Residents and Healthcare Workers. Franklin Woods Center, a Genesis HealthCare- (NYSE:GEN) (Genesis or the Company) affiliated nursing home, became one of the first long-term care facilities in Maryland to administer COVID-19 vaccinations today to both residents and staff. Genesis HealthCare is one of the nation’s largest providers of post-acute care. Franklin Woods Center, located in Baltimore, Maryland, hosted representatives from across the state at its center on Wednesday to witness this exciting milestone, including Maryland Governor Larry Hogan and President and CEO of the Health Facilities Association of Maryland, Joseph DeMattos, Jr. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Genesis Healthcare Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.8595 on 02/25/20, with the lowest value was $0.4010 for the same time period, recorded on 10/29/20.
Genesis Healthcare Inc. (GEN) full year performance was -64.32%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Genesis Healthcare Inc. shares are logging -68.34% during the 52-week period from high price, and 46.81% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.40 and $1.86.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 7746023 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Genesis Healthcare Inc. (GEN) recorded performance in the market was -64.10%, having the revenues showcasing 0.44% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 94.74M, as it employees total of 55000 workers.
Analysts verdict on Genesis Healthcare Inc. (GEN)
During the last month, 0 analysts gave the Genesis Healthcare Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.5781, with a change in the price was noted -0.3213. In a similar fashion, Genesis Healthcare Inc. posted a movement of -35.31% for the period of last 100 days, recording 1,171,001 in trading volumes.
Genesis Healthcare Inc. (GEN): Technical Analysis
Raw Stochastic average of Genesis Healthcare Inc. in the period of last 50 days is set at 64.97%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 51.79%. In the last 20 days, the company’s Stochastic %K was 42.40% and its Stochastic %D was recorded 40.33%.
Let’s take a glance in the erstwhile performances of Genesis Healthcare Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -64.10%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -19.80%, alongside a downfall of -64.32% for the period of the last 12 months. The shares increased approximately by 10.47% in the 7-day charts and went down by 23.26% in the period of the last 30 days. Common stock shares were driven by 0.44% during last recorded quarter.